The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...

Angelini Ventures has announced the appointment of Regina Hodits as its new managing director.

Endlyz is supported by leading investors, including SV Health Investors’ Dementia Discovery Fund, Oxford Science Enterprises, ...

The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa (HS) who have not ...

The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin combined with doxorubicin, ...

Elekta has announced a partnership with Azra AI to improve cancer registry workflows using AI-powered automation. Combining ...

The European Commission (EC) has approved ustekinumab for the treatment of moderately to severely active Crohn’s disease in ...

4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products ...